iii. It is not clear how systemic exposure compares between monkeys and humans in either
the mating or ovulation studies (described directly above). In a bioavailability monkey
study, three monkeys received 0.75 mg LNG (oral or subcutaneous), and the total
systemic exposure (area under the curve) of LNG was not quantified.
In conclusion, the rat data from Muller (2003) show that subcutaneous administration with LNG (50 μg/kg,
twice per day, for 2 days) early in the menstrual cycle inhibits ovulation and does not affect implantation.
The monkey studies from Ortiz (2004) also show LNG inhibits ovulation when administered early in the
cycle but the data did not show that LNG decreased pregnancy rates when administered close to
fertilization. These papers did not address the impact of LNG when dosed after implantation. The data,
however, are hard to extrapolate to consumer use of LNG-EC because it is not clear how the dosing
regimen in the animals compares to clinically relevant exposures of LNG, due to the lack of adequate
pharmacokinetic data in either the rat or monkey study.
2. Clinical Studies Evaluating the Effect of Levonorgestrel Emergency Contraception on Ovulation
a. Marions and colleagues (2004) published another human clinical study further examining the
postovulatory effects of LNG-EC; LNG again delayed or stopped ovulation, and was associated with a delay
in rise of pregnanediol in the time following the expected LH peak, and a lower estrone peak at the time
of expected LH peak. In this study, after a control cycle to determine the expected day of LH peak, 7
women were administered 2 doses of LNG 0.75 mg given 12 hours apart, 2 days prior to their expected
LH peak. Daily transvaginal ultrasounds were performed, as were daily urine assays for LH, pregnanediol
glucuronate, and estrone glucuronate. Follicle rupture did not occur in any participants. Similar to findings
in other studies, the LH peak did not occur or was attenuated and delayed in LNG cycles vs control cycles.
Pregnanediol levels rose more slowly in the LNG-exposed cycle than in the control cycle, reaching peak on
Day +9 (with Day 0 having been the expected LH peak day, 2 days after administration of LNG) as opposed
to Day +7 for the control cycle, but had a similar area under the concentration curve (AUC). Estrone levels
peaked on Day 0 for both the LNG and control cycles, with a lower Cmax for the LNG cycle. The authors
state that the latter two observations suggest that LNG-EC may have some effect in the luteal phase.
However, because ovulation did not occur, this postulation is moot, because pregnancy could not have
occurred anyway. It is unclear whether one can attribute an effect of LNG, or whether the observations
may be the natural findings of reduced luteal activity in an anovulatory cycle. Mean cycle length shortened
by 4 days with LNG vs control. Also, the study examined similar parameters for mifepristone, with each
participant receiving mifepristone in one cycle, then having a washout cycle with no drug given, then
receiving LNG in a third cycle. This presents a small possibility of confounding from mifepristone’s effects
in the prior cycle in the same participant.
b. Tirelli and colleagues (2008) published a study in which women with regular menstrual cycles were
enrolled within 72 hours of unprotected intercourse and received LNG 0.75 mg x 2 doses 12 hours apart.
The study included a subgroup of eight women who received LNG during Days 11-13 of the cycle, and who
underwent detailed evaluation with transvaginal ultrasound every 3 days starting on the day of
recruitment before LNG intake until follicular rupture was documented. This subgroup of eight women
also underwent endocrine blood sampling (LH, FSH, estradiol, and progesterone).
In seven of eight women, an anovulatory cycle was documented with no LH or FSH peak. In addition,
menstrual cycle length was significantly shortened. One of the eight women, who had received LNG on
Day 13 of the cycle, had an ovulatory cycle, and an LH surge. This study demonstrates that follicular phase
Page 13 of 27
Reference ID: 5100570